These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Update on the advisory committee on immunization practices' recommendations for use of herpes zoster vaccine. Weaver BA; J Am Osteopath Assoc; 2011 Oct; 111(10 Suppl 6):S31-3. PubMed ID: 22086893 [TBL] [Abstract][Full Text] [Related]
27. Stop shingles in its tracks. Lang PO; Hasso Y; Michel JP J Fam Pract; 2009 Oct; 58(10):531-4. PubMed ID: 19874731 [TBL] [Abstract][Full Text] [Related]
28. Herpes zoster and postherpetic neuralgia: prevention and management. Fashner J; Bell AL Am Fam Physician; 2011 Jun; 83(12):1432-7. PubMed ID: 21671543 [TBL] [Abstract][Full Text] [Related]
29. Vaccination for preventing postherpetic neuralgia. Chen N; Li Q; Zhang Y; Zhou M; Zhou D; He L Cochrane Database Syst Rev; 2011 Mar; (3):CD007795. PubMed ID: 21412911 [TBL] [Abstract][Full Text] [Related]
30. [Vaccination against Herpes Zoster after 50 years-of-age is effective]. MMW Fortschr Med; 2015 Aug; 157(14):74-5. PubMed ID: 26289853 [No Abstract] [Full Text] [Related]
31. Herpes zoster vaccination among adults aged 60 years and older, in the U.S., 2008. Lu PJ; Euler GL; Harpaz R Am J Prev Med; 2011 Feb; 40(2):e1-6. PubMed ID: 21238856 [TBL] [Abstract][Full Text] [Related]
32. [Herpes zoster and postherpetic neuralgia: advantages of the vaccination]. Cañada JL Rev Esp Quimioter; 2009 Nov; 22 Suppl 1():19-21. PubMed ID: 20084344 [No Abstract] [Full Text] [Related]
34. Zoster vaccine live for the prevention of shingles in the elderly patient. Zussman J; Young L Clin Interv Aging; 2008; 3(2):241-50. PubMed ID: 18686747 [TBL] [Abstract][Full Text] [Related]
35. Safety of herpes zoster vaccine in the shingles prevention study: a randomized trial. Simberkoff MS; Arbeit RD; Johnson GR; Oxman MN; Boardman KD; Williams HM; Levin MJ; Schmader KE; Gelb LD; Keay S; Neuzil K; Greenberg RN; Griffin MR; Davis LE; Morrison VA; Annunziato PW; Ann Intern Med; 2010 May; 152(9):545-54. PubMed ID: 20439572 [TBL] [Abstract][Full Text] [Related]
36. A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia. Holcomb K; Weinberg JM J Drugs Dermatol; 2006 Oct; 5(9):863-6. PubMed ID: 17039651 [TBL] [Abstract][Full Text] [Related]
37. Cost-effectiveness of vaccination against herpes zoster and postherpetic neuralgia: a critical review. Kawai K; Preaud E; Baron-Papillon F; Largeron N; Acosta CJ Vaccine; 2014 Mar; 32(15):1645-53. PubMed ID: 24534737 [TBL] [Abstract][Full Text] [Related]
38. Zostavax : a subcutaneous vaccine for the prevention of herpes zoster. Doan HQ; Ung B; Ramirez-Fort MK; Khan F; Tyring SK Expert Opin Biol Ther; 2013 Oct; 13(10):1467-77. PubMed ID: 23984934 [TBL] [Abstract][Full Text] [Related]